J Korean Neurol Assoc.  1994 Mar;12(1):60-69.

Clinical Follow-up Study of Myasthenia Gravis

Affiliations
  • 1Department of Neurology, College of Medicine, Seoul National University, Korea.
  • 2Department of Psychiatry, College of Medicine, Seoul National University, Korea.

Abstract

The authors studied clinical features, thymus histology, acetylcholine receptor antibody titers and the responses to multiple modalities of treatment in a consecutive series of 151 patients to know the characteristics of myasthenia gravis in Korea and to clarify the selection of theraputic regimens. The MG subjects were enrolled in Seoul National University Hospital Myasthenia Gravis Registry and followed for at least over 12 months from 1986 to 1991. The overall clinical features were nearly the same as other previous reports in other country except that pure ocular MG group showed younger age of onset and no significant sexual difference. When we classified 151 MG subjects by several criteria. The most valid grouping variables were whether the thymoma was present or not and whether the symptoms were generalized or not. However there was no difference of clinical features when they were divided by age of onset. Therefore we thought that it may be reasonable to classify the MG subjects by a few variables listed above for it will be helpful for comparing therapeutic modalities, estimating the prognosis, and understanding the basic pathomechanisms underlying each subgroups.


MeSH Terms

Acetylcholine
Age of Onset
Follow-Up Studies*
Humans
Korea
Myasthenia Gravis*
Prognosis
Seoul
Thymoma
Thymus Gland
Acetylcholine
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr